ZNF273
geneOn this page
Also known as HZF9
Summary
ZNF273 (zinc finger protein 273, HGNC:13067) is a protein-coding gene on chromosome 7q11.21, encoding Zinc finger protein 273 (Q14593). May be involved in transcriptional regulation.
This gene is a member of the krueppel C2H2-type zinc-finger protein family and encodes a protein with 13 C2H2-type zinc fingers and a KRAB domain. This nuclear protein is involved in transcriptional regulation. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 10793 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 82 total
- MANE Select transcript:
NM_021148
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13067 |
| Approved symbol | ZNF273 |
| Name | zinc finger protein 273 |
| Location | 7q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HZF9 |
| Ensembl gene | ENSG00000198039 |
| Ensembl biotype | protein_coding |
| OMIM | 604756 |
| Entrez | 10793 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding_CDS_not_defined, 2 protein_coding, 1 nonsense_mediated_decay
ENST00000395375, ENST00000465954, ENST00000471926, ENST00000476120, ENST00000476730, ENST00000489672, ENST00000527278, ENST00000936012
RefSeq mRNA: 8 — MANE Select: NM_021148
NM_001385643, NM_001385644, NM_001385645, NM_001385646, NM_001385649, NM_001385652, NM_001388021, NM_021148
CCDS: CCDS5528
Canonical transcript exons
ENST00000476120 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001864176 | 64927654 | 64930981 |
| ENSE00002194319 | 64903273 | 64903419 |
| ENSE00003514304 | 64918197 | 64918292 |
| ENSE00003590003 | 64917581 | 64917707 |
Expression profiles
Bgee: expression breadth ubiquitous, 247 present calls, max score 96.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.5425 / max 198.4478, expressed in 1535 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78826 | 8.5001 | 1468 |
| 78828 | 0.5185 | 231 |
| 78822 | 0.5062 | 138 |
| 78821 | 0.2699 | 128 |
| 78823 | 0.2234 | 110 |
| 78819 | 0.2059 | 105 |
| 78827 | 0.1891 | 100 |
| 78820 | 0.1294 | 72 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.97 | gold quality |
| upper leg skin | UBERON:0004262 | 96.95 | gold quality |
| skin of abdomen | UBERON:0001416 | 95.60 | gold quality |
| skin of hip | UBERON:0001554 | 95.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.08 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.88 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.87 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.57 | gold quality |
| skin of leg | UBERON:0001511 | 93.28 | gold quality |
| zone of skin | UBERON:0000014 | 93.06 | gold quality |
| cerebellum | UBERON:0002037 | 91.29 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 90.51 | gold quality |
| bronchus | UBERON:0002185 | 88.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.53 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 87.28 | gold quality |
| sperm | CL:0000019 | 86.72 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 84.89 | gold quality |
| vagina | UBERON:0000996 | 83.91 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.88 | gold quality |
| esophagus mucosa | UBERON:0002469 | 83.77 | gold quality |
| male germ cell | CL:0000015 | 83.60 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.60 | gold quality |
| upper arm skin | UBERON:0004263 | 83.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.35 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.28 | gold quality |
| minor salivary gland | UBERON:0001830 | 83.16 | gold quality |
| oral cavity | UBERON:0000167 | 82.27 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 82.15 | gold quality |
| nucleus accumbens | UBERON:0001882 | 82.14 | gold quality |
| ventricular zone | UBERON:0003053 | 81.94 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 49.73 |
| E-MTAB-9388 | yes | 9.07 |
| E-ANND-3 | yes | 8.30 |
| E-MTAB-7606 | no | 294.90 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000099025 |
Paralogs (18): ZNF430 (ENSG00000118620), ZNF92 (ENSG00000146757), ZNF66 (ENSG00000160229), ZNF22 (ENSG00000165512), ZNF680 (ENSG00000173041), ZNF114 (ENSG00000178150), ZFP41 (ENSG00000181638), ZNF730 (ENSG00000183850), ZNF479 (ENSG00000185177), ZNF626 (ENSG00000188171), ZNF431 (ENSG00000196705), ZNF100 (ENSG00000197020), ZNF257 (ENSG00000197134), ZNF98 (ENSG00000197360), ZNF675 (ENSG00000197372), ZNF737 (ENSG00000237440), ZNF253 (ENSG00000256771), ZNF723 (ENSG00000268696)
Protein
Protein identifiers
Zinc finger protein 273 — Q14593 (reviewed: Q14593)
Alternative names: Zinc finger protein HZF9
All UniProt accessions (2): E9PL30, Q14593
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q14593-1 | 1 | yes |
| Q14593-2 | 2 |
RefSeq proteins (8): NP_001372572, NP_001372573, NP_001372574, NP_001372575, NP_001372578, NP_001372581, NP_001374950, NP_066971* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (23 total): zinc finger region 13, region of interest 2, compositionally biased region 2, sequence variant 2, chain 1, domain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14593-F1 | 70.23 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 89 (showing top):
BROWNE_HCMV_INFECTION_16HR_UP, BROWNE_HCMV_INFECTION_12HR_UP, BILD_HRAS_ONCOGENIC_SIGNATURE, MODULE_206, SCHLOSSER_SERUM_RESPONSE_DN, FISCHER_DREAM_TARGETS, chr7q11, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, YAGI_AML_WITH_T_8_21_TRANSLOCATION, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP, JOHNSTONE_PARVB_TARGETS_3_DN, EGFR_UP.V1_DN, BCAT_GDS748_DN
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
518 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF273 | TP53BP1 | Q12888 | 555 |
| ZNF273 | CFAP68 | Q9H5F2 | 419 |
| ZNF273 | ERVV-1 | B6SEH8 | 398 |
| ZNF273 | TATDN2 | Q93075 | 336 |
| ZNF273 | NHLRC3 | Q5JS37 | 320 |
| ZNF273 | TMEM147 | Q9BVK8 | 297 |
| ZNF273 | TM4SF20 | Q53R12 | 294 |
| ZNF273 | RBMXL3 | Q8N7X1 | 288 |
| ZNF273 | ATP6AP2 | O75787 | 285 |
| ZNF273 | ZMYM4 | Q5VZL5 | 279 |
| ZNF273 | ACTB | P02570 | 279 |
| ZNF273 | FASTKD3 | Q14CZ7 | 270 |
| ZNF273 | RANBP6 | O60518 | 269 |
| ZNF273 | S100PBP | Q96BU1 | 265 |
| ZNF273 | ZNF706 | Q9Y5V0 | 265 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF273 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | ZNF273 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF707 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF512 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF273 | SP8 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CA14 | ZNF273 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Nrip3 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| Gsk3b | SYNPO2 | psi-mi:“MI:0914”(association) | 0.350 |
| TENT5A | GOLGA8R | psi-mi:“MI:0914”(association) | 0.350 |
| Kif2c | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| HDAC1 | TRAK1 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| PURG | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| PRR3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| ANOS1 | ZNF724 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS13 | KIF2A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (28): KRTAP10-5 (Two-hybrid), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-RNA), ZNF273 (Proximity Label-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS), ZNF273 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
755 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:64917575:TTTCA:T | acceptor_loss | 1.0000 |
| 7:64917576:TTCA:T | acceptor_loss | 1.0000 |
| 7:64917577:TCA:T | acceptor_loss | 1.0000 |
| 7:64917578:CA:C | acceptor_loss | 1.0000 |
| 7:64917668:A:T | donor_gain | 1.0000 |
| 7:64919921:A:AG | acceptor_gain | 1.0000 |
| 7:64903417:ATGG:A | donor_loss | 0.9900 |
| 7:64903418:TGG:T | donor_loss | 0.9900 |
| 7:64903420:G:T | donor_loss | 0.9900 |
| 7:64903421:T:A | donor_loss | 0.9900 |
| 7:64917579:A:AG | acceptor_gain | 0.9900 |
| 7:64917579:AG:A | acceptor_gain | 0.9900 |
| 7:64917579:AGG:A | acceptor_gain | 0.9900 |
| 7:64917580:G:GT | acceptor_gain | 0.9900 |
| 7:64917580:GG:G | acceptor_gain | 0.9900 |
| 7:64917580:GGG:G | acceptor_gain | 0.9900 |
| 7:64917580:GGGA:G | acceptor_gain | 0.9900 |
| 7:64917580:GGGAC:G | acceptor_gain | 0.9900 |
| 7:64917667:G:GT | donor_gain | 0.9900 |
| 7:64917705:TGGGT:T | donor_loss | 0.9900 |
| 7:64917706:GG:G | donor_gain | 0.9900 |
| 7:64917706:GGGTG:G | donor_loss | 0.9900 |
| 7:64917707:GG:G | donor_gain | 0.9900 |
| 7:64917707:GGT:G | donor_loss | 0.9900 |
| 7:64917708:G:GA | donor_loss | 0.9900 |
| 7:64917708:G:GG | donor_gain | 0.9900 |
| 7:64917709:T:TG | donor_loss | 0.9900 |
| 7:64917710:G:GG | donor_loss | 0.9900 |
| 7:64917713:GA:G | donor_gain | 0.9900 |
| 7:64918192:AACAG:A | acceptor_loss | 0.9900 |
AlphaMissense
3766 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:64928307:T:C | F327L | 0.986 |
| 7:64928309:T:A | F327L | 0.986 |
| 7:64928309:T:G | F327L | 0.986 |
| 7:64928391:T:C | F355L | 0.985 |
| 7:64928393:T:A | F355L | 0.985 |
| 7:64928393:T:G | F355L | 0.985 |
| 7:64928811:T:C | F495L | 0.979 |
| 7:64928813:T:A | F495L | 0.979 |
| 7:64928813:T:G | F495L | 0.979 |
| 7:64928475:T:C | F383L | 0.975 |
| 7:64928477:T:A | F383L | 0.975 |
| 7:64928477:T:G | F383L | 0.975 |
| 7:64928895:T:C | F523L | 0.970 |
| 7:64928897:T:A | F523L | 0.970 |
| 7:64928897:T:G | F523L | 0.970 |
| 7:64928643:T:C | F439L | 0.961 |
| 7:64928645:T:A | F439L | 0.961 |
| 7:64928645:T:G | F439L | 0.961 |
| 7:64928727:T:C | F467L | 0.961 |
| 7:64928729:T:A | F467L | 0.961 |
| 7:64928729:T:G | F467L | 0.961 |
| 7:64928902:G:C | R525P | 0.955 |
| 7:64928223:T:C | F299L | 0.953 |
| 7:64928225:T:A | F299L | 0.953 |
| 7:64928225:T:G | F299L | 0.953 |
| 7:64917614:T:C | F46L | 0.950 |
| 7:64917616:C:A | F46L | 0.950 |
| 7:64917616:C:G | F46L | 0.950 |
| 7:64928139:T:C | F271L | 0.946 |
| 7:64928141:T:A | F271L | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000007024 (7:64915091 A>G), RS1000034218 (7:64932074 A>T), RS1000070898 (7:64915632 G>A), RS1000148153 (7:64894594 A>AC), RS1000197860 (7:64893125 T>C,G), RS1000202257 (7:64895418 C>G), RS1000209821 (7:64886525 C>T), RS1000331973 (7:64908648 G>A,T), RS1000332823 (7:64901749 G>A,T), RS1000376911 (7:64901995 G>A), RS1000401487 (7:64877247 A>G,T), RS1000427530 (7:64927171 C>A,T), RS1000460143 (7:64926922 C>A,T), RS1000480825 (7:64915117 T>C), RS1000512907 (7:64914743 G>A,T)
Disease associations
OMIM: gene MIM:604756 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003427_11 | Alzheimer disease and age of onset | 6.000000e-07 |
| GCST009363_56 | Triglyceride levels x short total sleep time interaction (2df test) | 9.000000e-14 |
| GCST009369_1 | Triglyceride levels x short total sleep time interaction (1df test) | 3.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004847 | age at onset |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation, decreases expression, affects cotreatment | 2 |
| Valproic Acid | decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| clothianidin | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Coal | increases abundance, decreases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Gold | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Alzheimer disease